enVVeno Medical Corp NVNO
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
1/9
Piotroski F — financial health
-6.01
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$20.9M | -$23.8M | -$25.2M | -$24.9M | -$16.9M |
| Net income | -$19.5M | -$21.8M | -$23.5M | -$24.7M | -$16.5M |
| Operating cash flow | -$15.6M | -$16.8M | -$18.9M | -$15.6M | -$11.8M |
| Free cash flow | -$15.6M | -$16.9M | -$18.9M | -$15.7M | -$12.2M |
| Total assets | $29.6M | $45.0M | $48.6M | $41.7M | $57.7M |
| Total liabilities | $2.4M | $2.8M | $2.4M | $2.9M | $3.3M |
| Shareholders' equity | $27.1M | $42.2M | $46.2M | $38.7M | $54.4M |
| Ratios | |||||
| Return on assets | -65.9% | -48.5% | -48.4% | -59.2% | -28.6% |
| Return on equity | -71.8% | -51.8% | -50.9% | -63.7% | -30.4% |
| Current ratio | 13.58 | 20.88 | 34.23 | 25.78 | 34.84 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -6.01 (distress)
- Working capital / assets 0.903
- Retained earnings / assets -5.796
- EBIT / assets -0.707
- Equity / liabilities 11.155
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001661053 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.